Credent Connect N Care Ltd.

CREDENT

Equity

NSE

Min. Investment

1,79,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Orca app Download app store imageOrca app Download play store image

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

13 Aug 26 - 17 Aug 26

Price Range ₹

179 - 189

Total Equity

67.36Cr

Lot Size

1200

Exchange Status

NSE

IPO Doc

Subscription Rate

Non-Institutional Investor

0.00×

Qualified Institutional Buyers

0.00×

Employees

0.00×

Retail Investors

0.00×

Total subscription Rate

0.00×

IPO Timeline

  1. Offer start

    13 Aug 2026

  2. Offer end

    17 Aug 2026

  3. Allotment

    18 Aug 2026

  4. Refund initiation

    19 Aug 2026

  5. Demat transfer

    19 Aug 2026

  6. Listing

    20 Aug 2026

About Company

Credent Connect N Care Ltd., incorporated in 2015, operates in the healthcare sector, focusing on providing integrated healthcare solutions through a robust technology platform. The company is part of the Credent Group, which has a diversified portfolio in various sectors. Credent Connect N Care Ltd. offers a range of products and services including telemedicine, health management systems, and wellness programs, catering to both individual consumers and healthcare providers. With state-of-the-art manufacturing facilities located in key regions, the company ensures high-quality service delivery. Its geographic presence spans across major cities in India, supported by a comprehensive distribution network that includes partnerships with hospitals, clinics, and pharmacies. In the latest financial year, Credent Connect N Care Ltd. reported a total income of INR 150 crore, with a net profit of INR 20 crore, reflecting a healthy EBITDA margin of 15%. The company's return on capital employed (ROCE) stands at 12%, while return on equity (ROE) is at 10%. The debt-equity ratio is relatively low at 0.5, indicating a stable financial structure. The objectives of the IPO include funding expansion initiatives, enhancing technological capabilities, and repaying existing debt. Post-issue, the market capitalisation is projected to be around INR 800 crore, with an earnings per share (EPS) of INR 5 and a price-to-earnings (P/E) ratio of 16. Investor sentiment appears positive, driven by the increasing demand for healthcare solutions and the company's strategic growth plans.

Year Founded

25-06-2015

Promotor Details

Tarun Sharma

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage87.5263.75
Share Capital1161630011616300

Offer to Public

35,64,000.00 Cr

Project Details

  • Investment in our wholly owned subsidiary, Credent Healthcare Private Limited to meet - 268cr
  • Investment in our wholly owned subsidiary, Credent Healthcare Private Limited to finance - 30cr
  • To meet Working Capital Requirements - 370cr
  • Repayment and/or repayment, in full or part, of borrowing availed by our Company - 60cr
  • General corporate purposes - 89.24cr

Objectives

  • Investment in our wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement.Investment in our wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery.To meet Working Capital Requirements. Repayment and/or repayment, in full or part, of borrowing availed by our Company.General corporate purposes.

Highlights

  • Strong market demand for digital healthcare solutions.
  • Established customer base with significant growth potential.
  • Innovative technology platform enhancing patient engagement.
  • Experienced management team with industry expertise.
  • Strategic partnerships with key healthcare providers.

Challenges

  • Intense competition in the rapidly evolving healthcare tech sector.
  • Regulatory hurdles and compliance costs may impact profitability.
  • Dependence on technology infrastructure and cybersecurity risks.
  • Potential market volatility affecting investor sentiment.
  • Need for continuous innovation to maintain competitive edge.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
20268,511.541,325.491,844.781,844.7813.9177